Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

One year outcomes of retropupillary iris-claw Artisan intraocular lens in patients with inadequate capsular support

Poster Details

First Author: K. Baig CANADA

Co Author(s):    Y. Yang   E. Santiago   N. Noordeh   J. Compan           

Abstract Details


The implantation of retropupillary iris-claw artisan intraocular lens (IOL) has the advantage of avoiding corneal complications of an anterior chamber intraocular lens and is technically easier to perform than a posterior chamber lens. The purpose of this study is to evaluate the technique, efficacy, and safety of artisan retropupillary iris-claw lens in a long-term follow-up study.


Retrospective chart review at University of Ottawa Eye Institute, Ottawa, Canada


This study included 35 eyes (32 patients) that underwent implantation of retropupillary artisan intraocular lens alone or combined with intraocular lens exchange between 2012 and 2015. Ethics approval was obtained from The Ottawa Hospital Research Ethics Board. Preoperative, surgical and postoperative data were collected. Outcomes including best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), intraocular pressure, number of glaucoma medications, lens position, intraoperative and postoperative complications were assessed at regular intervals during a 1 year interval. Visual acuity was converted to logMAR. Descriptive and inferential statistics were performed.


35 eyes were included, with 28 eyes undergoing implantation of artisan lens alone and 7 eyes undergoing implantation of artisan lens combined with IOL exchange. Indications for surgery included aphakia (n=23), aphkia/corneal decompensation (n=6), IOL subluxation (n=3), pseudophakic bullous keratopathy (n=2) and uveitis-glaucoma-hyphema (n=1). The median follow up was 9 months. UCVA improved or remained stable in 95% (33/35) of eyes over the follow up period. The median number of glaucoma medications at latest follow up was 1 (range 0 to 3). Complications included retinal detachment (n=2), corneal decompensation (n=9), transitory iritis (n=3), IOP rise (n=3) and lens decentration (n=1).


Retropupillary implantation of artisan iris-claw intraocular lens is an effective technique in patients with inadequate capsular outcome, with stable visual outcomes over long term.

Financial Disclosure:


Back to Poster listing